The cumulative probability of vitrectomy at 16 weeks in diabetic retinopathy patients with vitreous hemorrhage was 12% in those who received ranibizumab treatment and 17% in patients who had saline injections, researchers reported in JAMA Ophthalmology.
Ranibizumab, saline show similar vitrectomy outcomes
SmartBrief Job Listings for Health Care
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
|Director of Clinical Research||
Regenesis Biomedical, Inc.
Meridian Health Plan
|Assistant Vice President - Dental Director||